Literature DB >> 2777372

Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber.

A B Onderdonk1, R L Cisneros, J H Crabb, R W Finberg, D L Kasper.   

Abstract

A bacterial containment chamber was used to evaluate the peritoneal cellular response to Bacteroides fragilis during intraperitoneal challenge. This containment system was also used to determine the fate of bacteria within the peritoneal cavities of animals immunized, either actively or through adoptive transfer of cells or cell lysates, with the capsular polysaccharide of B. fragilis. This system demonstrated that the dominant cell types in the peritoneal cavities within 48 h of implantation of the containment chambers containing B. fragilis were neutrophils and macrophages. However, the early cellular response in immunized animals included an increase in the lymphocyte population within 4 h of challenge which was not detected in naive animals. In immunized animals, a later dramatic increase in the lymphocyte population at approximately 4 to 6 days following implantation of the containment chambers occurred. This increase in the lymphocyte population in immunized animals coincided with a decline in the viable bacterial counts within the chambers from 10(8) to 10(9) CFU/ml to less than 10(2) CFU/ml. A similar decline was not seen in naive animals challenged in the same manner. Killing of B. fragilis within containment chambers occurred when spleen cells, T cells, or lysates of T cells from actively immunized animals were passively transferred to naive recipient animals. It was shown that the factor responsible for bacterial killing was not antibody mediated, since bacteria contained within dialysis sacs with an exclusion of 50 kilodaltons were still killed in this model. Moreover, removal of T cells from adoptively transferred cell populations before transfer abrogated the decline in viable bacterial populations. The postulated mechanisms by which this bacterial killing occurred are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777372      PMCID: PMC260766          DOI: 10.1128/iai.57.10.3030-3037.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.

Authors:  D F Zaleznik; R W Finberg; M E Shapiro; A B Onderdonk; D L Kasper
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

2.  Anaerobic infections of the female genital tract: bacteriologic and therapeutic aspects.

Authors:  H Thadepalli; S L Gorbach; L Keith
Journal:  Am J Obstet Gynecol       Date:  1973-12-15       Impact factor: 8.661

3.  Abdominal trauma, anaerobes, and antibiotics.

Authors:  H Thadepalli; S L Gorbach; P W Broido; J Norsen; L Nyhus
Journal:  Surg Gynecol Obstet       Date:  1973-08

4.  Leukotactic factors in health and disease.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1971-09       Impact factor: 4.307

5.  Wound healing.

Authors:  R Ross
Journal:  Sci Am       Date:  1969-06       Impact factor: 2.142

6.  Use of implantable intraperitoneal diffusion chambers to study Bordetella pertussis pathogenesis: growth and toxin production in vivo.

Authors:  K D Coleman; L H Wetterlow
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

7.  Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.

Authors:  A B Onderdonk; R B Markham; D F Zaleznik; R L Cisneros; D L Kasper
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

Authors:  D L Kasper; A B Onderdonk; J Crabb; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

9.  Cellular immunity to Bacteroides fragilis capsular polysaccharide.

Authors:  M E Shapiro; A B Onderdonk; D L Kasper; R W Finberg
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

  9 in total
  2 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.

Authors:  F C Gibson; A O Tzianabos; A B Onderdonk
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.